Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Did you get back in?
Yeah... I got to the computer Thursday morning and I saw $4.94 on the bid at the open. The smart me thought sell, the dumb me said nah no worries until we start getting closer to six. Thursday and Friday were full of shouldve couldve wouldve until I found something else to focus on. If it kept going up I would be glad I didnt sell so... I am just glad BIOL is set up nicely to prosper and those who own this stock should enjoy the ride. Looking forward to a fresh week.
Jonathan Woolf, Director of Romulus Films, a United Kingdom based investment company, said, "After the stem cell asset acquisition transaction is completed, BAC and the BioTime family of companies will hold the largest concentration of stem cell and regenerative medicine assets and experience in the world."
$6 is what I am looking for as a near term goal as well, for now lets bust through $5.
Almost at $5 db!
BIOLASE Reports 2012 Fourth Quarter, Year-End Results
http://ih.advfn.com/p.php?pid=nmona&article=56601596&symbol=BIOL
Federico Pignatelli, Chairman and CEO, said, "For the past two years, BIOLASE has undergone a radical restructuring, which was substantially completed at year-end 2012. Now we can concentrate on continued execution and the meaningful expansion of our business in 2013 and beyond."
"Overall 2012 was a year of execution where we met or exceeded our guidance throughout the year and went on to generate cash from operations in the fourth quarter. We have expanded our offerings of internally developed lasers and in-licensed cone beam and CAD/CAM imaging products while significantly strengthening our intellectual property and patent portfolio. As a result of these efforts, our annual revenue for 2012 increased significantly over 2011 and more than doubled that of 2010," noted Pignatelli. "With a number of solid initiatives in place, including new product launches, the recent approval of over 80 new procedures in 19 additional medical markets, and the launch of EPIC V-Series in to the veterinary market, we expect BIOLASE to continue to grow strongly in 2013."
Congrats on the profit, you timed that buy point perfectly.
You still in on your February 4th @ $2.71 per share buy?
Hope BIOL makes you some $$$. I am riding 1040 free shares I have accumulated flipping this one since my sister became a dentist and told me about the product. Things are looking great for the company right now, as long as they keep it up this should be a fun one to own. Good luck db.
With the recent FDA approval to use BIOL lasers for medical procedures other than dentistry and the expansion into other countries, this company is on the rise for sure. I love that the CEO is working for $1 to prove he is working to better the stock price too! We are early to the party on this board, there are only 12 followers on this stock. Crazy, good luck to us SuperSquirrel and the other 10 followers.
Anyone else enjoying this BIOL run with me? This stock is looking good!
BIOLASE CEO to Continue at Symbolic Annual Cash Salary of $1.00
http://ih.advfn.com/p.php?pid=nmona&article=56594030&symbol=BIOL
"it simply makes sense to align my interest as a shareholder with that of all shareholders, the ultimate owners of BIOLASE. My goal is for BIOLASE to generate continued growth and improved financial performance. As the Chairman and CEO, I will not benefit unless our shareholders benefit. It remains my firm belief that a CEO's compensation should be tied only to the financial performance of the companies they lead and I invite others to follow my example."
Thank you Mr. Pignatelli
What are the "odds" Mr. Rabin would be willing to do this....
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading dental laser manufacturer and distributor, announced today that Chief Executive Officer Federico Pignatelli will continue at a symbolic annual cash salary of $1.00 for the year ending December 31, 2013.
Pignatelli stated, "In my continuing effort to align management's interest with the interests of our shareholders, as it should be for every listed Company, and so for BIOLASE, the Board of Directors has accepted my offer to continue to serve as the CEO for a symbolic annual cash salary of $1.00 for 2013. To reiterate what I have said in the past, it simply makes sense to align my interest as a shareholder with that of all shareholders, the ultimate owners of BIOLASE. My goal is for BIOLASE to generate continued growth and improved financial performance. As the Chairman and CEO, I will not benefit unless our shareholders benefit. It remains my firm belief that a CEO's compensation should be tied only to the financial performance of the companies they lead and I invite others to follow my example."
Maybe its in the cards....
BIOLASE Recognized With "Best AEEDC Dubai Booth Activities Award" at Recent UAE Dental Conference & Arab Dental Exhibition
http://ih.advfn.com/p.php?pid=nmona&article=56249201&symbol=BIOL
Held from February 5 - 7, 2013, in Dubai, United Arab Emirates
WaterLase and EPIC diode technology is so attractive that we had the busiest booth at the AEEDC
more so than any other company including such prestigious companies as Sirona Dental Systems, Inc. (NASDAQ: SIRO), The Procter & Gamble, Co. (NYSE: PG), and Colgate-Palmolive Co. (NYSE: CL)
In lasers, where we are the undisputed global leader
This year's exhibition had over 1,000 dental equipment suppliers from 70 countries and over 28,000 attendees
3rd time exhibiting at AEEDC Dubai and it has been great to observe the tremendous growth in the interest of dental lasers in the region during that period.
The best part is that we are not just a dental laser company anymore. Recent FDA approvals opens the door to this type of exposure in many more fields of medicine. The future holds promising outlooks on growth and revenues for BIOLASE.
Time to retest last Augusts highs.
Wow... just reread the PR. It is pretty substantial news. Multiplied revenue streams. Stock is responding... Another 52 week high 3.93
NEW 52 WEEK HIGH TODAY 3.85
Nice timing! Congrats!
BIOLASE Receives FDA Clearance for Its 940nm Diolase 10(TM) Diode Soft Tissue Laser for a Broad Spectrum of Medical Procedures
http://ih.advfn.com/p.php?pid=nmona&article=56168822&symbol=BIOL
the U.S. Food and Drug Administration (FDA) has cleared the 940nm Diolase 10 diode soft tissue laser for use in 19 additional medical markets including: ear, nose and throat, oral surgery, arthroscopy, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery, cardiac surgery, thoracic surgery, urology, dermatology, aesthetics, and vascular surgery. This FDA clearance includes over 80 different procedures.
Maybe this is giving it a boost.
Molycorp Inc (NYSE:MCP): Molibdenos Y Metales S.a. (10% Owner) purchased 15,000,000 shares at a price of $6.00.
Read more: http://tvenews.com/smw/40982/Insiders-Bought-These-Stocks-on-Jan-31#ixzz2Jeo8GDh6
BIOLASE Announces Launch of Occulase Website
a website to showcase OCCULASE, a wholly-owned subsidiary of BIOLASE, dedicated to expanding the multiple applications of its proprietary WaterLase technology and other related intellectual property into ophthalmology.
Ophthalmology is the branch of medicine that deals with the anatomy, physiology and diseases of the eye.
http://ih.advfn.com/p.php?pid=nmona&article=55959578&symbol=BIOL
BIOLASE Expects to Report Positive Cash Flow From Operations for Q4 2012
http://ih.advfn.com/p.php?pid=nmona&article=55940224&symbol=BIOL
Federico Pignatelli, Chairman and CEO. "The trends we are seeing in the adoption of dental lasers also give us confidence in achieving continued double-digit growth of our core dental franchise. Based on our current plans, we expect the Company will continue to generate positive cash flow from operations for the overall year ending December 31, 2013."
BTX staying strong... green again... nice volume. Something tells me this is the stock to own for the future if you want a piece of the regenerative medicine sector.
Looks like this...
Molycorp Says 2013 Revenue, Cash Flow to Fall Short of Expectations
means more than...
Molycorp Announces New Rare Earth Complex is Operational and Ramping Up Toward Full-Scale Production
because...
MCP is currently down -19% aka $2.05 per share... ouch.
Molycorp Announces New Rare Earth Complex is Operational and Ramping Up Toward Full-Scale Production
http://ih.advfn.com/p.php?pid=nmona&article=55783752&symbol=MCP
Revenue Expected to Exceed $18 Million for 2012 Fourth Quarter
http://ih.advfn.com/p.php?pid=nmona&article=55726339&symbol=BIOL
based on a preliminary review of its financial performance for the fourth quarter ended December 31, 2012, the Company expects to exceed its previous guidance and report net revenue in excess of $18 million.
http://ih.advfn.com/p.php?pid=nmona&article=54593604&symbol=BTX
BioTime, Inc. Issues Open Letter to Shareholders of Geron Corporation
Biolase shares soar as dental laser device gets approval
http://www.reuters.com/article/2012/10/03/us-biolase-dentaldevice-idUSBRE8920U720121003
Strong uptrend here since the low towards the end of June. This should be a great long term hold.
I have been very happy with the current uptrend. Now you say there is an upgrade... nice. Keep it up GERN! I hope the reason it has been going up is that people in the know are continuously accumulating shares, driving the pps up before the company delivers positive news on one of its upcoming catalysts. Us regular Joe Schmos are just along for the ride... its getting interesting. There is plenty of upside here, I cant believe this board isnt more active.
GERN showing signs of life, nice move today... lets hope its the start of a long term consistent uptrend.
Bought some for my 4 month old nephew in his custodial account. Got him in @ 4.85
Crazy, back to the waiting game.
I will be watching! Thanks again for all the updates.
Nice! Thanks for keeping up with it and sharing. The offering numbers look good too. Just over 17 million outstanding. I think we need to remember the 180 day lockup date so we dont get burnt when they can cash out.
BIOLASE Introduces Next Generation Diode Laser, the EPIC 10(TM)
http://ih.advfn.com/p.php?pid=nmona&article=52286958&symbol=BLTI
12 to 14 is not to bad. When it drops to the single digits it will be perfect for 1,000 share swing trades... just like OCZ.
BLTI will host a conference call on Wednesday, May 9th, at 4:30 p.m. Eastern Time to discuss its operating results for the first quarter ended March 31, 2012, and to answer questions. The Company's results release will be distributed at approximately 4:05 p.m. Eastern Time that same day.
Picked up some 5.18's, nice discounted shares.
Thanks for sharing the links.